.Amgen has discussed (PDF) the initial stage 3 data on its own $400 thousand eczema medicine, connec...
.Biogen and also UCB's gamble on developing in to stage 3 astride an unsuccessful study tries to hav...
.Italian biotech Aptadir Therapies has introduced with the commitment that its pipeline of preclinic...
.Surge Lifestyle Sciences has actually satisfied its objective in a Duchenne muscular dystrophy (DMD...
.After a couple of years in biotech, Mike Quigley, Ph.D., is going back to the pharma fold, occupyin...
.Achilles Therapies has shreded its approach. The British biotech is actually stopping work on its c...
.Aligos Therapeutics is actually declaring a midstage succeed in metabolic-dysfunction linked steato...
.Basilea Pharmaceutica's job developing new antifungals has acquired a substantial boost coming from...
.Possessing presently gathered up the USA civil liberties to Capricor Therapies' late-stage Duchenne...
.After pushing the decision date for Applied Therapies' metabolic condition drug govorestat, the FDA...